コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 em Xc- antiporter to activate a metabotropic glutamate receptor.
2 able AMPA receptors and group I metabotropic glutamate receptors.
3 elease by presynaptic Group III metabotropic glutamate receptors.
4 and dephosphorylation of synaptic AMPA-type glutamate receptors.
5 depressed by the activation of metabotropic glutamate receptors.
6 mPFC blockade of AMPA-type but not NMDA-type glutamate receptors.
7 which SHANK2 may interact with post-synaptic glutamate receptors.
8 a positive allosteric modulator of AMPA-type glutamate receptors.
9 internalization of both NMDA- and AMPA-type glutamate receptors.
10 tamate release, and presynaptic metabotropic glutamate receptors.
11 tly mediated by signaling through microglial glutamate receptors.
12 roxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors.
13 n via the activation of group I metabotropic glutamate receptors.
14 c or glutamatergic neurons) and postsynaptic glutamate receptors.
15 titive/fast off-rate antagonist of NMDA-type glutamate receptors.
16 f homeostatic plasticity, up-scaling of AMPA-glutamate receptors.
17 atergic neurons and regulate the activity of glutamate receptors.
21 mergence of glutamate-activated metabotropic glutamate receptor 1 (mGluR1) signaling, are critical to
22 psin-1, postsynaptic density protein 95, and glutamate receptor 1 and medial prefrontal cortex spine
23 29, glutamate decarboxylase 1, metabotropic glutamate receptor 1, and excitatory amino acid transpor
24 were female-specific changes in metabotropic glutamate receptor 1, NMDA receptor 2A, alpha-amino-3-hy
25 tive antibody antagonist of the metabotropic glutamate receptor-1 (BBB-mGluR1), a widely abundant CNS
26 rin-R, cell adhesion molecules, metabotropic glutamate receptor-1 (mGluR1), voltage-gated sodium chan
28 allosteric modulators (PAM) of metabotropic glutamate receptor 2 (mGluR2) are a potential therapy fo
32 iveness (leptin receptors Lepr, metabotropic glutamate receptors-2 mGlu2, neuropeptide-Y NPY, and min
34 synaptic protein synthesis, the metabotropic glutamate receptor 5 (mGlu5) protein, is significantly r
35 vel role of GluD1 in regulating metabotropic glutamate receptor 5 (mGlu5) signaling in the hippocampu
36 modulators (NAMs) targeting the metabotropic glutamate receptor 5 (mGlu5) subtype are currently in cl
38 uding disorders associated with metabotropic glutamate receptor 5 (mGluR5) and dopaminergic dysfuncti
39 ithout prior treatment with the metabotropic glutamate receptor 5 (mGluR5) antagonist 2-methyl-6-(phe
40 advance the novel concept that metabotropic glutamate receptor 5 (mGluR5) fails to engage endocannab
42 allosteric modulators (NAM) of metabotropic glutamate receptor 5 (mGluR5) have been implicated as a
45 tic glutamate, which stimulates metabotropic glutamate receptor 5 (mGluR5) on a small population of i
46 s release glutamate to activate metabotropic glutamate receptor 5 (mGluR5) on astrocytes, evoking Ca(
47 suggest that inhibition of the metabotropic glutamate receptor 5 (mGluR5) receptor might hold therap
49 uces a re-emergence of immature metabotropic glutamate receptor 5 (mGluR5) signaling in S1 astroglia,
50 utamate spillover, initiating a metabotropic glutamate receptor 5 (mGluR5)-dependent increase in nitr
55 in associates via transmembrane metabotropic glutamate receptor 5 with the intracellular protein medi
56 ABA cells that was dependent on metabotropic glutamate receptor 5, and cannabinoid receptor 1 (CB1).
57 R1, and GABABR2 levels, whereas metabotropic glutamate receptor 5, NMDA receptor 2B, GluR2, and GABAA
58 taining protein 12, mitofusin2, metabotropic glutamate receptor 5, p21-activated kinase 7, and Ras-re
60 glutamatergic transmission, the metabotropic glutamate receptor 6 and voltage-dependent calcium chann
61 inally, we show that sustained activation of glutamate receptors, a condition occurring in brain isch
62 ular transport machinery, and down-regulates Glutamate receptor A1 trafficking and neurotransmitter r
63 tive allosteric modulators of the ionotropic glutamate receptor A2 (GluA2) are promising lead compoun
64 w that JhI-21 suppresses postsynaptic muscle glutamate receptor abundance, and that JhI-21 expression
70 tic levels of the GluA1 subunit of AMPA-type glutamate receptors after 48 h silencing with the Na(+)
72 urface expression of NMDA-type and AMPA-type glutamate receptors, along with prominent functional imp
73 rologous expression of excitatory ionotropic glutamate receptor AMPA subunits in Xenopus oocytes, we
74 Positive allosteric modulators of AMPA-type glutamate receptors (ampakines) have been shown to rescu
80 sity protein-95 (PSD-95) localizes AMPA-type glutamate receptors (AMPARs) to postsynaptic sites of gl
91 vivo imaging of N-methyl-d-aspartate (NMDA) glutamate receptor and gamma-aminobutyric acid (GABA)-A
92 some of these spines are immunopositive for glutamate receptor and postsynaptic density proteins (vi
95 ed tau from infiltrating spines, dislocating glutamate receptors and impairing synaptic function in c
96 2+) in MNTB neurons, which is independent of glutamate receptors and is absent in neurons from ASIC1a
100 ide insight into the activation mechanism of glutamate receptors and the complex conformational space
101 ethyl-4-isoxazole propionic acid (AMPA)-type glutamate receptors and the function of synapses in the
102 nding gating across the family of ionotropic glutamate receptors and the role of AMPA receptors in ex
103 by modulating the clustering of postsynaptic glutamate receptors and thereby regulating the strength
104 fers basal glutamate activation of AMPA-type glutamate receptors and therefore decreases baseline exc
105 en shown to directly inhibit AMPA receptors (glutamate receptors), and to change cell energetics thro
107 ons with VLEs, requires group I metabotropic glutamate receptors, and has a presynaptic mechanism.
108 rgeting multiple ionotropic and metabotropic glutamate receptors, and intracellular cascades involved
110 H2 )5 [D-Tyr(2) ,Thr(4) ]OVT, the ionotropic glutamate receptor antagonist kynurenate or the GABAA an
112 effects of ketamine, an N-methyl-D-aspartate glutamate receptor antagonist, have not been fully eluci
114 tic standpoint because numerous metabotropic glutamate receptor antagonists are available, many of wh
117 ne, and/or the N-methyl-d-aspartate class of glutamate receptor antagonists have been shown to be eff
118 cularly those involving N-methyl-D-aspartate glutamate receptor antagonists, to illustrate principles
128 ARs), one of three subfamilies of ionotropic glutamate receptors, as well as the putative KAR auxilia
131 um channels to a trans-synaptic complex with glutamate receptors at the visual system's first synapse
132 ner drugs (DREADDs) or by the treatment with glutamate receptor blockers attenuated misfolded tau acc
134 aptic cell to prevent block of NMDA-specific glutamate receptors by Mg(2+) The ratio of postsynaptic
140 y recruitment of calcium-permeable AMPA-type glutamate receptors (CP-AMPARs) after drug withdrawal re
141 RP in neurons abolishes group 1 metabotropic glutamate receptor-dependent DGK activity combined with
144 le subanesthetic dose of ketamine normalized glutamate receptor expression and synaptic function of g
147 ated CaMKII and Rac1 activity, reduced GluN1 glutamate receptor expression, and impaired synaptic pla
148 c compartment of mutant NMJs include reduced glutamate receptor field size, and altered glutamate rec
149 ng in an increased fraction of post-synaptic glutamate receptor fields that lack the active zone scaf
152 esponsiveness and the link between PMCA2 and glutamate receptors, GABA receptors (GABARs), and glutam
153 ated nonsynonymous SNP, rs34144324, was in a glutamate receptor gene (GRID2, P = 8.65 x 10(-6) [OR 3.
154 acent to the analogous residue in the Grid2 (glutamate receptor) gene, which is mutated in the mouse
156 f Mint orthologue LIN-10, internalization of glutamate receptor GLR-1, and depression of GLR-1-mediat
158 resynaptic Cav1.3 clusters with postsynaptic glutamate receptor GluA4 and PSD-95 clusters was signifi
159 age dependent increase in the levels of the glutamate receptor, GluN2B in aged MHCI knockout mice, w
160 ys a role on the recycling and clustering of glutamate receptors (GLUR) at the postsynaptic density.
163 s underlying gating, numerous structures for glutamate receptors have been solved in complexes with a
165 manner requiring intact group 1 metabotropic glutamate receptors, Homer2, phospholipase C, and/or pho
166 TD in PE animals was rescued by metabotropic glutamate receptor I activation, suggesting that PE did
167 ry synapses is determined by the presence of glutamate receptors (i.e. AMPA, NMDA, and kainate recept
169 rocytic processes were blocked by ionotropic glutamate receptor (iGluR) antagonists, tetrodotoxin, zi
174 are classified as members of the ionotropic glutamate receptor (iGluR) superfamily on the basis of s
176 ly encodes homologs of vertebrate ionotropic glutamate receptors (iGluRs) that are distantly related
177 channels that together with other ionotropic glutamate receptors (iGluRs), the NMDA and kainate recep
179 role of synaptic trafficking of AMPA-type of glutamate receptors in HSP, Mecp2 KO neurons have lower
180 te patch-clamp experiments verified that the glutamate receptors in question were located on astrocyt
182 pendence to show that GluA1 subunits of AMPA glutamate receptors in the nucleus accumbens (NAc), a br
183 relationship between the number of AMPA-type glutamate receptors in the PSD and synaptic strength.
184 elf-administration of cocaine increases AMPA glutamate receptors in the VTA, and this effect enhances
186 al measures to demonstrate that metabotropic glutamate receptor-induced sensitization of TRPA1 nocice
188 the GluA2 subunit of the AMPAR and requires glutamate receptor interacting protein 1 (GRIP1) interac
189 pled to the actin cytoskeleton to facilitate glutamate receptor internalization has not been demonstr
194 and the gating characteristics of tetrameric glutamate receptor ion channels are determined by their
195 t encoding the glutamate receptor subunit B, glutamate receptor ionotropic AMPA 2 (GRIA2), modifies a
196 ting candidate genes on chromosome 1 (GRIK3 (glutamate receptor ionotropic kainate 3)), chromosome 4
197 ble sensory receptor (the variant ionotropic glutamate receptor IR75b) and attraction-mediating circu
198 lutamate receptors to those of AMPA-specific glutamate receptors is decreased, but the postsynaptic c
199 of the FMRP pathway by group I metabotropic glutamate receptors is involved in regulating synaptic p
200 tic current from activation of NMDA-specific glutamate receptors is progressively increased during tr
202 namics simulations of the GluA2 AMPA subtype glutamate receptor ligand-binding domain (LBD) dimers to
203 R2 and excitatory light-activated ionotropic glutamate receptor LiGluR yielded a distribution of expr
205 e ion channel two pore channel 1 (TPC1), and glutamate receptor-like channels GLR3.3 and GLR3.6.
206 ates that expression of GRM3, a metabotropic glutamate receptor mainly expressed in mammalian central
207 erefore, our results suggest that ionotropic glutamate receptors may have been conserved throughout p
209 N-methyl-d-aspartate (NMDA)-type ionotropic glutamate receptors mediate excitatory neurotransmission
211 isoxazole propionic acid)-subtype ionotropic glutamate receptors mediate fast excitatory neurotransmi
215 he spatiotemporal profiles of GABA, ACh, and glutamate receptor-mediated synaptic activity in DSGCs e
216 lutamate receptor GLR-1 and the metabotropic glutamate receptor MGL-1 in one of the primary circuits
217 anslation downstream of group I metabotropic glutamate receptors (mGlu1/5) is a core pathophysiology
218 ation of one particular GPCR, a metabotropic glutamate receptor (mGluR), can reduce cone synaptic tra
221 onist activation of the group I metabotropic glutamate receptor mGluR1 increases the strength of this
224 ional signalling by the group I metabotropic glutamate receptors, mGluR1 and mGluR5, occurs through G
225 irects GAD67 expression via the metabotropic glutamate receptor mGluR1beta on GABApre terminals and r
228 mine the significance of type 5 metabotropic glutamate receptors (mGluR5s) for behavioral and circuit
229 Upon binding glutamate, the metabotropic glutamate receptor mGluR6 activates the heterotrimeric G
230 alization of beta-DG with dystrophin and the glutamate receptor mGluR6 is disrupted, and the post-syn
231 ransmission is initiated by the metabotropic glutamate receptor, mGluR6, that signals via the G-prote
232 execution, EAAC1 limits group I metabotropic glutamate receptor (mGluRI) activation, facilitates D1 d
233 that EAAC1 limits activation of metabotropic glutamate receptors (mGluRIs) in the striatum and, by do
235 ivation of postsynaptic group I metabotropic glutamate receptors (mGluRs) and Ca(2+) -permeable AMPA
238 ses, we show that activation of metabotropic glutamate receptors (mGluRs) by general and group I-spec
239 notropic glutamate receptors or metabotropic glutamate receptors (mGluRs) or orthosteric agonists of
242 the visual system, presynaptic metabotropic glutamate receptors (mGluRs) regulate cone photoreceptor
244 ule subunit counting on class C metabotropic glutamate receptors (mGluRs), we map dimerization determ
248 ngthening by increasing N-methyl D-aspartate glutamate receptor (NMDAR) internalization through depho
252 converge on regulation of NMDA and AMPA-type glutamate receptors (NMDAR, AMPAR), including long-term
253 al synaptic responses, mediated by NMDA-type glutamate receptor (NMDARs) activation, form the cellula
254 th synaptic functions by depleting NMDA-type glutamate receptors (NMDARs) from the neuronal surface a
257 n in AMPK-Thr(P)(172) levels was mediated by glutamate receptors of the N-methyl-d-aspartate (NMDA) s
258 emic injections of antagonists of ionotropic glutamate receptors or metabotropic glutamate receptors
259 ion of PNNs in regulating the trafficking of glutamate receptors places them in a critical position t
260 ns as a primary site of persistent AMPA-type glutamate receptor plasticity by two widely used psychos
262 resynaptic calcium channels and postsynaptic glutamate receptor proteins across the synaptic cleft.
263 basis of allosteric inhibition in ionotropic glutamate receptors, providing key insights into how iGl
264 -in-colorectal-cancer', and the postsynaptic glutamate-receptor-related proteins GluD1 and GluD2.
265 accelerates the turnover of GluA2-containing glutamate receptors, revealing a novel mechanism that co
266 ct excess "gain of function" of metabotropic glutamate receptor signaling at an important cerebellar
268 that the activation of group I metabotropic glutamate receptor signaling though the fragile X mental
272 emerging evidence that altered metabotropic glutamate receptor signalling and disrupted calcium home
273 tion of the Gq-coupled, Group 1 metabotropic glutamate receptors, specifically mGlu5, is implicated i
274 vel concept that a breakdown of metabotropic glutamate receptor subtype mGluR5 and endocannabinoid si
275 overy of allosteric ligands for metabotropic glutamate receptor subtypes 1-5 and 7 (mGlu1-5,7) highli
277 one adenosine in the transcript encoding the glutamate receptor subunit B, glutamate receptor ionotro
278 ct of EphB2 may be mediated by the AMPA-type glutamate receptor subunit GluA2, which can become assoc
279 itution in the homologous but distinct mouse glutamate receptor subunit Grid2 is associated with Lurc
281 rally required for dendritic development and glutamate receptor surface expression, core-glycosylated
284 Rs) are a subtype of postsynaptic ionotropic glutamate receptors that function as molecular coinciden
285 -aspartate-receptors (NMDARs) are ionotropic glutamate receptors that function in synaptic transmissi
286 ess kainate receptors (KARs), a subfamily of glutamate receptors that modulate neurite outgrowth and
287 s the remodeling of the ionotropic AMPA-type glutamate receptors that underlie fast excitatory synapt
288 itatory and inhibitory connectivity and GABA/Glutamate receptor time constant based on neural mass mo
291 ctive excitatory synapses by recruiting AMPA glutamate receptors to the postsynaptic cell surface.
292 o of postsynaptic responses of NMDA-specific glutamate receptors to those of AMPA-specific glutamate
294 rity of the transferrin receptor and several glutamate receptor types, resulting in their appearance
295 ignaling through ionotropic and metabotropic glutamate receptors, ultimately resulting in synaptic dy
296 Synaptic transmission mediated by AMPA-type glutamate receptors was potentiated in the NAc shell 10-
297 GRIA2 subunits leads to a calcium-permeable glutamate receptor, which can promote cell migration and
298 tors (KARs) consist of a class of ionotropic glutamate receptors, which exert diverse pre- and postsy
299 Correspondingly, AMPA-subtype ionotropic glutamate receptors, which mediate the majority of excit
300 ulating lateral diffusion and positioning of glutamate receptors within the postsynaptic density (PSD
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。